Karen Claesen

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Recombinant Human

Dendritic Cells

Peripheral Blood

Top Venues

International journal of molecular sciences

Journal of clinical medicine

Translational stroke research

This page only lists publications with an associated author ORCID identifier.

Publications

Karen Claesen, Joni De Loose, Pieter Van Wielendaele, Emilie De Bruyn, Yani Sim, Sofie Thys, Ingrid De Meester, Dirk Hendriks
ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation. International journal of molecular sciences 24 (4) (2023)
Karen Claesen, Joni De Loose, Pieter Van Wielendaele, Emilie De Bruyn, Yani Sim, Sofie Thys, Ingrid De Meester, Dirk Hendriks
ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation. International journal of molecular sciences 24 (4) (2023)
Karen Claesen, Joni De Loose, Pieter Van Wielendaele, Emilie De Bruyn, Yani Sim, Sofie Thys, Ingrid De Meester, Dirk Hendriks
ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation. International journal of molecular sciences 24 (4) (2023)
Karen Claesen, Joni De Loose, Pieter Van Wielendaele, Emilie De Bruyn, Yani Sim, Sofie Thys, Ingrid De Meester, Dirk Hendriks
ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation. International journal of molecular sciences 24 (4) (2023)
Karen Claesen, Joni De Loose, Pieter Van Wielendaele, Emilie De Bruyn, Yani Sim, Sofie Thys, Ingrid De Meester, Dirk Hendriks
ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation. International journal of molecular sciences 24 (4) (2023)
Karen Claesen, Yani Sim, An Bracke, Michelle De Bruyn, Emilie De Hert, Gwendolyn Vliegen, An Hotterbeekx, Alexandra Vujkovic, Lida van Petersen, Fien H R De Winter, Isabel Brosius, Caroline Theunissen, Sabrina van Ierssel, Maartje van Frankenhuijsen, Erika Vlieghe, Koen Vercauteren, Samir Kumar-Singh, Ingrid De Meester, Dirk Hendriks
Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity Prognosis. Journal of clinical medicine 11 (6) (2022)
Joachim C Mertens, Vanessa Blanc-Guillemaud, Karen Claesen, Pedro Cardona, Dirk Hendriks, Benoit Tyl, Carlos A Molina
Carboxypeptidase U (TAFIa) Is Rapidly Activated and Deactivated Following Thrombolysis and Thrombectomy in Stroke Patients. Translational stroke research (2021)
Karen Claesen, Lynn Roth, Joachim C Mertens, Karlijn Hermans, Yani Sim, Dirk Hendriks
Pleiotropic Effects of Atorvastatin Result in a Downregulation of the Carboxypeptidase U System (CPU, TAFIa, CPB2) in a Mouse Model of Advanced Atherosclerosis. Pharmaceutics 13 (10) (2021)
Karen Claesen, Joachim C Mertens, Dorien Leenaerts, Dirk Hendriks
Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery? International journal of molecular sciences 22 (2) (2021)